BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26701781)

  • 1. Single-Tubed Wild-Type Blocking Quantitative PCR Detection Assay for the Sensitive Detection of Codon 12 and 13 KRAS Mutations.
    Huang JF; Zeng DZ; Duan GJ; Shi Y; Deng GH; Xia H; Xu HQ; Zhao N; Fu WL; Huang Q
    PLoS One; 2015; 10(12):e0145698. PubMed ID: 26701781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High sensitive mutation analysis on KRAS gene using LNA/DNA chimeras as PCR amplification blockers of wild-type alleles.
    Huang Q; Wang GY; Huang JF; Zhang B; Fu WL
    Mol Cell Probes; 2010 Dec; 24(6):376-80. PubMed ID: 20732413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive and selective detections of codon 12 and 13 KRAS mutations in a single tube using modified wild-type blocker.
    Su N; Wei K; Zhao N; Wang L; Duan GJ; Ren XD; Qu XM; Huang Q
    Clin Chim Acta; 2019 Jul; 494():123-131. PubMed ID: 30902586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-sensitivity PCR method for detecting BRAF V600E mutations in metastatic colorectal cancer using LNA/DNA chimeras to block wild-type alleles.
    Chen D; Huang JF; Xia H; Duan GJ; Chuai ZR; Yang Z; Fu WL; Huang Q
    Anal Bioanal Chem; 2014 Apr; 406(9-10):2477-87. PubMed ID: 24500755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of KRAS codon 12 and 13 mutations by mutant-enriched PCR assay.
    Chang YS; Er TK; Lu HC; Yeh KT; Chang JG
    Clin Chim Acta; 2014 Sep; 436():169-75. PubMed ID: 24863805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a Multiplex Allele-Specific Polymerase Chain Reaction Assay for Detection of KRAS Gene Mutations in Formalin-Fixed, Paraffin-Embedded Tissues from Colorectal Cancer Patients.
    Seekhuntod S; Thavarungkul P; Chaichanawongsaroj N
    PLoS One; 2016; 11(1):e0147672. PubMed ID: 26812617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SensiScreen®KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations.
    Riva A; BØrgesen M; Guldmann-Christensen M; Hauge Kyneb M; Voogd K; Andersen C; Epistolio S; Merlo E; Yding Wolff T; Hamilton-Dutoit S; Lorenzen J; Christensen UB; Frattini M
    PLoS One; 2017; 12(6):e0178027. PubMed ID: 28636636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive multiplex detection of KRAS codons 12 and 13 mutations in paraffin-embedded tissue specimens.
    Laosinchai-Wolf W; Ye F; Tran V; Yang Z; White R; Bloom K; Choppa P; Labourier E
    J Clin Pathol; 2011 Jan; 64(1):30-6. PubMed ID: 21030527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of targeted next-generation sequencing for RAS mutation detection in FFPE colorectal cancer tissues: comparison with Sanger sequencing and ARMS-Scorpion real-time PCR.
    Gao J; Wu H; Wang L; Zhang H; Duan H; Lu J; Liang Z
    BMJ Open; 2016 Jan; 6(1):e009532. PubMed ID: 26747035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
    Zhang X; Wang Y; Gao N; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-time PCR-based method for the rapid detection of extended RAS mutations using bridged nucleic acids in colorectal cancer.
    Iida T; Mizuno Y; Kaizaki Y
    Clin Chim Acta; 2019 Feb; 489():164-168. PubMed ID: 29111094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of fixation artifacts and threshold selection on high resolution melting analysis for KRAS mutation screening.
    Pérez-Báez W; García-Latorre EA; Maldonado-Martínez HA; Coronado-Martínez I; Flores-García L; Taja-Chayeb L
    Mol Cell Probes; 2017 Oct; 35():34-43. PubMed ID: 28627450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of real-time PCR-optimized oligonucleotide probe method and Sanger sequencing for detection of KRAS mutations in colorectal and lung carcinomas].
    Qiu T; Ling Y; Chen Z; Shan L; Guo L; Lü N; Ying JM
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):599-602. PubMed ID: 23157827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of KRAS mutations in colorectal cancer with Fast COLD-PCR.
    Carotenuto P; Roma C; Cozzolino S; Fenizia F; Rachiglio AM; Tatangelo F; Iannaccone A; Baron L; Botti G; Normanno N
    Int J Oncol; 2012 Feb; 40(2):378-84. PubMed ID: 21971641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRAS gene mutation in a series of unselected colorectal carcinoma patients with prognostic morphological correlations: a pyrosequencing method improved by nested PCR.
    de Macêdo MP; de Melo FM; Lisboa BC; Andrade LD; de Souza Begnami MD; Junior SA; Ribeiro HS; Soares FA; Carraro DM; da Cunha IW
    Exp Mol Pathol; 2015 Jun; 98(3):563-7. PubMed ID: 25835782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of KRAS mutations in colorectal carcinoma patients with an integrated PCR/sequencing and real-time PCR approach.
    Carotenuto P; Roma C; Rachiglio AM; Tatangelo F; Pinto C; Ciardiello F; Nappi O; Iaffaioli RV; Botti G; Normanno N
    Pharmacogenomics; 2010 Aug; 11(8):1169-79. PubMed ID: 20712532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wild‑type blocking pcr coupled with internal competitive amplified fragment improved the detection of rare mutation of KRAS.
    Peng J; Wei K; Zhao X; Yang K; Wang H; Zhang Y; Guo M; He J; Wu H; Li Y; Zhao N; Huang Q; Fu W
    Mol Med Rep; 2017 Sep; 16(3):2726-2732. PubMed ID: 28677778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of
    Olmedillas-López S; Lévano-Linares DC; Alexandre CLA; Vega-Clemente L; Sánchez EL; Villagrasa A; Ruíz-Tovar J; García-Arranz M; García-Olmo D
    World J Gastroenterol; 2017 Oct; 23(39):7087-7097. PubMed ID: 29093617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive detection of trace amounts of KRAS codon 12 mutations by a fast and novel one-step technique.
    Xie F; Huang J; Qu S; Wu W; Jiang J; Wang H; Wang S; Liu Q; Zhang S; Xu L; Gao S; Zhang Y; Zhao J; Chen W
    Clin Biochem; 2014 Nov; 47(16-17):237-42. PubMed ID: 25192863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.
    Heideman DA; Lurkin I; Doeleman M; Smit EF; Verheul HM; Meijer GA; Snijders PJ; Thunnissen E; Zwarthoff EC
    J Mol Diagn; 2012; 14(3):247-55. PubMed ID: 22425762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.